Abstract: A migration apparatus for an (integrated access and backhaul) IAB-node, applicable to a first terminal equipment, the first terminal equipment comprising a terminal equipment served by a first IAB-node and/or a terminal equipment served by a descendant IAB-node of the first IAB-node includes a first memory configured to store first configuration information, the first configuration information comprising security configuration configured by a target IAB donor node, and first applying processor circuitry configured to apply the security configuration in a stored first configuration information when first indication information is obtained or the security configuration in the stored first configuration information comprises security configuration corresponding to a selected or reselected cell.

Abstract: An integrated access and backhaul (IAB) communication method includes detecting, by an IAB node, that on a backhaul link between the IAB node and a parent node, a radio link failure (RLF) occurs or a radio link failure (RLF) recovery is successful, or a radio link failure (RLF) recovery is failure, and transmitting, by the IAB node, RLF indication information to an IAB child node or a terminal equipment by using a Backhaul Adaptation Protocol (BAP) control Protocol Data Unit (PDU), the RLF indication information being used for indicating one of at least two backhaul radio link failure (BH RLF) types.

Abstract: A method and an apparatus for detecting beam failure. The method comprises: receiving a beam failure instance indication by a medium access control (MAC) entity of a terminal equipment, incrementing a transmission reception point (TRP)-specific beam failure indication count by 1, and in a case where the TRP-specific beam failure indication count is greater than or equal to a TRP-specific beam failure instance maximum count, determining that a beam failure occurs in a transmission reception point or beam failure recovery (BFR) of the transmission reception point is triggered or a beam failure indication of the transmission reception point is triggered.

Abstract: A signal transmission and reception apparatus, applicable in an integrated access and backhaul (IAB)-node, includes a transmitter, configured to transmit a congestion reporting message to a donor central unit of the integrated access and backhaul node (IAB-donor CU), the congestion reporting message being used to indicate a load status of a communication link of the integrated access and backhaul node.

Abstract: A signal transmission and reception method and apparatus and a communication system, the signal transmission and reception apparatus being applicable in an IAB-DU and includes a first receiver configured to receive uplink data transmitted to a parent node of an integrated access and backhaul (IAB) node via an uplink; and a first transmitter configured to transmit flow control feedback information to a child node of the integrated access and backhaul node, the flow control feedback information being used to indicate a load status of uplink transmission of the integrated access and backhaul node.

Abstract: A beam management method, an apparatus thereof and an intelligent beam management device. The method includes querying a database according to position information (x0, y0, z0) of a terminal equipment, the database including multiple entries, each entry containing beam measurement related information of a point (xi, yi, zi), selecting entries corresponding to points in a predetermined range of the terminal equipment from the database; selecting no more than a first number of IDs of base station transmitter beams with the highest number of occurrences from all the selected entries; and determining a base station transmitter beam serving the terminal equipment according to whether beams corresponding to the no more than a first number of IDs of base station transmitter beams belong to a serving base station or another base station.

Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.

Abstract: A routing selection apparatus, configured in a first node, includes a processor configured to perform local re-routing when at least one of the following conditions is satisfied that a BH RLF indication is received from a second node, first flow control feedback information is received from a third node, and the first flow control feedback information indicates that data congestion occurs in the third node, a payload of a first egress BH RLC channel exceeds a desired level, and a payload corresponding to a first routing identity exceeds a desired level.

Abstract: A resource allocation apparatus includes processor circuitry configured to acquire UE bearer information, and processor circuitry configured to allocate a resource for an MAC SDU of a UE bearer k in a logical channel j, allocation of the resource being related to the number of tokens of UE bearer in the logical channel j.

Abstract: A beam management method, an apparatus thereof and an intelligent beam management device. The method includes: querying a database according to position information (x0, y0, z0) of a terminal equipment, the database including multiple entries, each entry containing beam measurement related information of a point (xi, yi, zi), selecting entries corresponding to points in a predetermined range of the terminal equipment from the database; selecting no more than a first number of base station transmitter beam identifiers with the highest number of occurrences from all the selected entries; and determining a base station transmitter beam serving the terminal equipment according to whether beams corresponding to the no more than a first number of base station transmitter beam identifiers belong to a serving base station or another base station.

Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.

Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.

Abstract: The present invention provides a pharmaceutical composition or food composition for preventing, alleviating or treating muscular diseases comprising ginsenoside Rh2 as an active ingredient.

Abstract: A beam management method, an apparatus thereof and an intelligent beam management device. The method includes: querying a database according to position information (x0, y0, z0) of a terminal equipment, the database including multiple entries, each entry containing beam measurement related information of a point (xi, yi, zi), selecting entries corresponding to points in a predetermined range of the terminal equipment from the database; selecting no more than a first number of IDs of base station transmitter beams with the highest number of occurrences from all the selected entries; and determining a base station transmitter beam serving the terminal equipment according to whether beams corresponding to the no more than a first number of IDs of base station transmitter beams belong to a serving base station or another base station.

Abstract: The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.

Abstract: Embodiments of this disclosure disclose a state monitoring apparatus and method for a wireless network. The method includes: collecting measurement parameters of a link to be monitored in the wireless network; calculating the collected measurement parameters to obtain statistical metrics of each measurement parameter; according to a predetermined change relationship between statistical metrics and possibilities of states, determining a possibility of each state reflected by each statistical metric; and performing fusion processing on the possibilities of states reflected by a plurality of statistical metrics of the link to be monitored, and determining a state of the link to be monitored. The network state may be efficiently monitored, and accuracy of the monitoring result may be improved.

Abstract: Embodiments of this disclosure provide an information transmission method and apparatus and electronic equipment. The information transmission method apparatus is used for transmitting a network topology information frame (TI frame) of network topology information, the apparatus including: a transmitting/receiving unit configured to transmit and/or receive a media access control (MAC) layer frame of a network protocol; the network topology information frame (TI frame) is loaded into a payload of the MAC layer frame. According to this disclosure, transmission modes of the network topology information may be made more flexible.

Abstract: Methods for preventing step-height difference of flash and logic gates in FinFET devices and related devices are provided. Embodiments include forming fins in flash and logic regions; recessing an oxide exposing an upper portion of the fins; forming an oxide liner over the upper portion in the flash region; forming a polysilicon gate over and perpendicular to the fins in both regions; removing the gate from the logic region and patterning the gate in the flash region forming a separate gate over each fin; forming an ONO layer over the gates in the flash region; forming a second polysilicon gate over and perpendicular to the fins in both regions; planarizing the second polysilicon gate exposing a portion of the ONO layer over the gates in the flash region; forming and patterning a hardmask, exposing STI regions between the flash and logic regions; and forming an ILD over the STI regions.

Abstract: The present invention provides a pharmaceutical composition or food composition for preventing, alleviating or treating muscular diseases comprising ginsenoside Rh2 as an active ingredient.